PMID: 8600200Mar 1, 1996Paper

Psychotic symptoms in Parkinson's disease patients with dementia

Journal of the American Geriatrics Society
D NaimarkD V Jeste

Abstract

To assess the prevalence of psychotic symptoms in a group of patients with Parkinson's disease (PD) and dementia and examine the association of psychotic symptoms with neuropsychiatric problems, the level of distress reported by caregivers, and cognitive and functional impairment. The psychotic and nonpsychotic patients with PD dementia were compared on a series of demographic, neuropsychiatric, behavioral, caregiver complaint, and cognitive measures. The database from nine university-based State of California Alzheimer's Disease Diagnostic and Treatment Centers (ADDTCs). 101 patients diagnosed with PD. A total of 36 of the 101 patients (35.6%) had either hallucinations, delusions, or both. The psychotic patients had significantly more insomnia, confusion, agitation, personality changes, and self-care problems and were noted by their caregivers to be significantly more unmanageable at home than their nonpsychotic counterparts. On cognitive scales, psychotic patients were significantly more impaired. Many patients with PD and dementia experience psychosis. Psychotic symptoms in PD dementia patients are associated with major behavioral, cognitive, and functional problems.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Aug 1, 1991·Clinical Neuropharmacology·J H Friedman
Feb 1, 1992·The American Journal of Psychiatry·D V JesteL J Thal
Nov 1, 1991·Journal of Neuropathology and Experimental Neurology·W Paulus, K Jellinger
Aug 1, 1990·Journal of the American Geriatrics Society·J K CooperP G Weiler
Aug 1, 1990·The American Journal of Psychiatry·C SteeleM Folstein
May 1, 1989·The American Journal of Psychiatry·R E Wragg, D V Jeste
Apr 10, 1986·The New England Journal of Medicine·R Katzman
Jan 1, 1989·Biological Psychiatry·W C Drevets, E H Rubin
Jul 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G BlessedM Roth
Jan 1, 1993·Journal of the American Geriatrics Society·J Corey-BloomL J Thal

❮ Previous
Next ❯

Citations

Dec 10, 2015·Expert Opinion on Drug Safety·Roberto CeravoloUbaldo Bonuccelli
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
Dec 5, 2008·Journal of Psychosocial Nursing and Mental Health Services·Roy R Reeves, James C Brister
Jan 1, 1997·New Directions for Mental Health Services·D V Jeste, F S McClure
Jun 15, 2015·Progress in Neurobiology·Roy LardenoijeBart P F Rutten
Dec 5, 2003·Journal of Geriatric Psychiatry and Neurology·Nicholas HoehJoel Streim
Dec 21, 2000·Current Psychiatry Reports·C Ballard, M Walker
Sep 20, 2008·Journal of Psychopharmacology·A W ZuardiV Tumas
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·P J ReadingI G McKeith
Oct 24, 2017·Clinical Neuropharmacology·Joseph BergmanChanoch Miodownik
Nov 22, 2017·Neurodegenerative Disease Management·Ruth B SchneiderIrene H Richard
Mar 11, 1999·The New England Journal of Medicine·J L Cummings
Jul 23, 1999·Pharmacotherapy·Y C ChanG Neufeld
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·William G OndoJoseph Jankovic
Apr 1, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·William G OndoGeorge Ringholz
Apr 14, 2009·Topics in Magnetic Resonance Imaging : TMRI·Jean Théberge
Jul 7, 2005·Journal of Neurology·Spiridon Papapetropoulos, D C Mash
Apr 19, 2005·Journal of Neurology·Spiridon PapapetropoulosJohn Ellul
Jan 28, 2018·Current Psychiatry Reports·Shyam C Panchal, William G Ondo
Dec 18, 2019·Psychiatry and Clinical Neurosciences·Natalie SeilerBrian O'Donoghue
Mar 23, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Kangdi ZhuJohan Marinus
Feb 24, 2001·Annals of the New York Academy of Sciences·I G McKeith
Dec 7, 2019·Journal of Geriatric Psychiatry and Neurology·Akira KuritaMegumi Suzuki
Feb 1, 1997·Journal of the American Geriatrics Society·J H FriedmanG T Stebbins
Dec 21, 2000·Current Psychiatry Reports·D Aarsland, K Karlsen
Aug 20, 2020·CNS Spectrums·Jeffery L CummingsStephen M Stahl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
J H Friedman
Journal of the American Geriatrics Society
J H FriedmanG T Stebbins
© 2021 Meta ULC. All rights reserved